TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory

Darren R Hargrave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.